Literature DB >> 26572152

Identification of CTNNB1 mutations, CTNNB1 amplifications, and an Axin2 splice variant in juvenile angiofibromas.

Silke Wemmert1, Vivienne Willnecker2, Philipp Kulas2, Stefanie Weber2, Cornelia Lerner2, Sabrina Berndt2, Olaf Wendler3, Bernhard Schick2.   

Abstract

Juvenile angiofibromas (JAs) are benign fibro-vascular tumors occurring nearly exclusively in adolescent males. Even less is known about this rare tumor entity, alterations affecting the Wnt-pathway seem to play a pivotal role in tumor biology as activating CTNNB1 mutations have been detected. However, the knowledge of Wnt-pathway changes is still limited. Therefore, we aimed to determine in JAs further insight into Wnt/β-catenin pathway components. In our present study, genetic alterations of the Wnt-pathway members CTNNB1, APC, GSK3β, and Axin2 detected by metaphase comparative genomic hybridization (CGH) were shown to result in elevated transcript levels in the majority of JA samples compared to nasal mucosa stroma (p < 0.001, p = 0.001, p = 0.046, and p = 0.006, respectively). Additionally, amplifications of CTNNB1 were validated by fluorescence in situ hybridization (FISH) and genomic qPCR. Moreover, our mutation analysis detected already known mutations as well as, to the best of our knowledge, mutations and an interstitial deletion of CTNNB1 not described in JAs before. Additionally, a so far unknown transcribed Axin2 splice variant was found, but no further Axin2 mutations. Taken together, our current study supports the importance of aberrant Wnt-signaling as a common event in JAs, most likely by the observed genetic alterations driven by mutations, interstitial deletions but also amplifications of CTNNB1 contributing to the stabilization of β-catenin.

Entities:  

Keywords:  FISH; Juvenile angiofibroma; Mutations; qPCR; β-Catenin

Mesh:

Substances:

Year:  2015        PMID: 26572152     DOI: 10.1007/s13277-015-4422-y

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  41 in total

1.  Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling.

Authors:  W Liu; X Dong; M Mai; R S Seelan; K Taniguchi; K K Krishnadath; K C Halling; J M Cunningham; L A Boardman; C Qian; E Christensen; S S Schmidt; P C Roche; D I Smith; S N Thibodeau
Journal:  Nat Genet       Date:  2000-10       Impact factor: 38.330

Review 2.  New aspects of pathogenesis of juvenile angiofibroma.

Authors:  Bernhard Schick; Steffi Urbschat
Journal:  Hosp Med       Date:  2004-05

Review 3.  Patterns of genomic imbalances in human solid tumors (Review).

Authors:  E Gebhart; T Liehr
Journal:  Int J Oncol       Date:  2000-02       Impact factor: 5.650

4.  Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta.

Authors:  M J Hart; R de los Santos; I N Albert; B Rubinfeld; P Polakis
Journal:  Curr Biol       Date:  1998-05-07       Impact factor: 10.834

Review 5.  The links between axin and carcinogenesis.

Authors:  S Salahshor; J R Woodgett
Journal:  J Clin Pathol       Date:  2005-03       Impact factor: 3.411

6.  beta-catenin (CTNNB1) gene amplification: a new mechanism of protein overexpression in cancer.

Authors:  Gianpaolo Suriano; Nikoleta Vrcelj; Janine Senz; Paulo Ferreira; Hamid Masoudi; Kelley Cox; Sergio Nabais; Carlos Lopes; José Carlos Machado; Raquel Seruca; Fatima Carneiro; David G Huntsman
Journal:  Genes Chromosomes Cancer       Date:  2005-03       Impact factor: 5.006

7.  Comprehensive genomic analysis identifies MDM2 and AURKA as novel amplified genes in juvenile angiofibromas.

Authors:  Bernhard Schick; Silke Wemmert; Ulrike Bechtel; Piero Nicolai; Thiemo Hofmann; Wieslaw Golabek; Steffi Urbschat
Journal:  Head Neck       Date:  2007-05       Impact factor: 3.147

8.  Expression of collagen types I, II and III in juvenile angiofibromas.

Authors:  M Gramann; O Wendler; L Haeberle; B Schick
Journal:  Cells Tissues Organs       Date:  2008-09-25       Impact factor: 2.481

9.  Laminin expression in juvenile angiofibroma indicates vessel's early developmental stage.

Authors:  Veronika Starlinger; Olaf Wendler; Monika Gramann; Bernhard Schick
Journal:  Acta Otolaryngol       Date:  2007-12       Impact factor: 1.494

10.  Juvenile nasopharyngeal angiofibroma and familial adenomatous polyposis: an association?

Authors:  A S Ferouz; R M Mohr; P Paul
Journal:  Otolaryngol Head Neck Surg       Date:  1995-10       Impact factor: 5.591

View more
  3 in total

1.  Inhibition of CK2 Reduces NG2 Expression in Juvenile Angiofibroma.

Authors:  Anne S Boewe; Silke Wemmert; Philipp Kulas; Bernhard Schick; Claudia Götz; Selina Wrublewsky; Mathias Montenarh; Michael D Menger; Matthias W Laschke; Emmanuel Ampofo
Journal:  Biomedicines       Date:  2022-04-21

Review 2.  Soft Tissue Special Issue: Fibroblastic and Myofibroblastic Neoplasms of the Head and Neck.

Authors:  Esther Baranov; Jason L Hornick
Journal:  Head Neck Pathol       Date:  2020-01-16

3.  Neural Crest Stem Cells in Juvenile Angiofibromas.

Authors:  Bernhard Schick; Lukas Pillong; Gentiana Wenzel; Silke Wemmert
Journal:  Int J Mol Sci       Date:  2022-02-09       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.